Leaderboards/head and neck surgical oncology

head and neck surgical oncology

Last updated June 11, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Amy C. Moreno
The University of Texas MD Anderson Cancer Center
99
2
Clifton D. Fuller
The University of Texas MD Anderson Cancer Center
90
3
Ladislav Czakó
Comenius University Bratislava
80
4
Branislav Gális
Comenius University Bratislava
70
5
Zhigong Wei
Sichuan University
60
6
Xingchen Peng
Sichuan University
50
7
Hilary C. McCrary
University of Utah
30
8
Ayman Bali
Jena University Hospital
20
9
David Pertzborn
Jena University Hospital
10

Rising Stars Papers

1
Neoadjuvant tislelizumab with afatinib for locally advanced head and neck squamous cell carcinoma (neoCHANCE-1): a phase 2 clinical trial
Nature Communications|2025
1 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Douglas E. Peterson
UConn Health
99
2
Andrea Lorenzi
University of Turin
90
3
Alessandro Tel
University of Udine
80
4
Leila T. Tchelebi
Northwell Health
70
5
Anne Rullière
Centre Hospitalier Universitaire de Poitiers
60
6
Gianluca Sampieri
University of Toronto
50
7
Nikhil Bellamkonda
University of Utah
40
8
Kathleen T. Fitzgerald
Cork University Hospital
40
9
Brian Hayama
Japanese Foundation For Cancer Research
30
10
Ryan Daniel
University of Toronto
20

Emerging Leaders Papers

Insufficient data

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Jean Louis Lefèbvre
Centre Oscar Lambret
99
2
Patrick K. Ha
University of California, San Francisco
90
3
Enriqueta Felip
Vall d'Hebron Hospital Universitari
80
4
Kurt R. Zinn
University of Alabama at Birmingham
70
5
Mark A. Varvares
Saint Louis University
60
6
J.J. Caudell
Moffitt Cancer Center
50
7
William C. Faquin
American Society of Clinical Oncology
40
8
Bruce H. Campbell
Medical College of Wisconsin
30
9
David A. Palma
Western University
20
10
Jørn Herrstedt
University of Southern Denmark
10

All-Time Leaders Papers

1
Preoperative Chemotherapy Plus Surgery Versus Surgery Plus Adjuvant Chemotherapy Versus Surgery Alone in Early-Stage Non–Small-Cell Lung Cancer
Journal of Clinical Oncology|2010
426 cit.
2
Expression of KIT (CD117) in Neoplasms of the Head and Neck: An Ancillary Marker for Adenoid Cystic Carcinoma
Modern Pathology|2003
183 cit.
3
Overview of Checkpoint Inhibitors Mechanism of Action: Role of Immune-Related Adverse Events and Their Treatment on Progression of Underlying Cancer
Frontiers in Medicine|2022
84 cit.
4
Fluorescence In Situ Hybridization and Immunohistochemistry as Diagnostic Methods for ALK Positive Non-Small Cell Lung Cancer Patients
PLoS ONE|2013
70 cit.

Reagents for head and neck surgical oncology

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Recommended

Best all-around

Cell Signaling Technology

beta-Actin (13E5) Rabbit Monoclonal Antibody (HRP Conjugate)

#5125$477
View Evidence →Cell Signaling Technology

Phospho-GSK-3 beta (Thr390) Antibody

#3548$362
View Evidence →Cell Signaling Technology

COX IV (D6I4K) Rabbit Monoclonal Antibody (BSA and Azide Free)

#17100$865
View Evidence →

🌟 All-Time

Most validated

Cell Signaling Technology

MLXIP/MondoA (F8A8L) Rabbit Monoclonal Antibody

Cited in 5 papers
#72133$161
View Evidence →Cell Signaling Technology

LPCAT1 (E4V4B) Rabbit Monoclonal Antibody (BSA and Azide Free)

#81677$865
View Evidence →Cell Signaling Technology

Merlin/Ezrin/Radixin/Moesin (D1P8I) Rabbit Monoclonal Antibody

#23292$161
View Evidence →